Home Applications 065122 Application 065122
Type ANDA
Sponsor FRESENIUS KABI USA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE INJECTABLE;INJECTION EQ 10MG BASE/ML No No 002 TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE INJECTABLE;INJECTION EQ 40MG BASE/ML No Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065122-001 TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 A065122-002 TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP 2002-11-29 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP 2002-11-29 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP 2002-11-29 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP 2002-11-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065122-001 TOBRAMYCIN SULFATE EQ 10MG BASE/ML INJECTABLE / INJECTION AP 2002-11-29 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A065122-002 TOBRAMYCIN SULFATE EQ 40MG BASE/ML INJECTABLE / INJECTION AP RS 2002-11-29 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 7 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 63323-305 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current 63323-305 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current 63323-305 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current 63323-306 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current 63323-306 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current 63323-306 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current 63323-306 Tobramycin TOBRAMYCIN SULFATE Fresenius Kabi USA, LLC ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 39417 SUPPL 2014-02-04